{"id":"https://openalex.org/W2014865890","doi":"https://doi.org/10.1158/1535-7163.targ-09-c63","title":"Abstract C63: Biological characterization of GSK2126458, a novel and potent inhibitor of phosphoinositide 3-kinase and the mammalian target of rapamycin (mTOR)","display_name":"Abstract C63: Biological characterization of GSK2126458, a novel and potent inhibitor of phosphoinositide 3-kinase and the mammalian target of rapamycin (mTOR)","alternate_titles":[],"publication_year":2009,"publication_date":"2009-12-01","ids":{"openalex":"https://openalex.org/W2014865890","doi":"https://doi.org/10.1158/1535-7163.targ-09-c63","mag":"2014865890"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-09-c63","doi":"https://doi.org/10.1158/1535-7163.targ-09-c63","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-09-c63","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2014865890"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002805151","display_name":"Mary Ann Hardwicke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mary Ann Hardwicke","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012523367","display_name":"Hong Lu","orcid":"https://orcid.org/0000-0002-4171-016X","observed_orcids":["https://orcid.org/0000-0002-4171-016X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hong Lu","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111827109","display_name":"Lusong Luo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lusong Luo","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111415811","display_name":"Melody A. Diamond","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Melody Diamond","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109971483","display_name":"Chiu-Mei Sung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chiu-Mei Sung","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005435471","display_name":"Jeffrey D. Carson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey D. Carson","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023259390","display_name":"Ramona N Plant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ramona Plant","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036867504","display_name":"Christine M. Gardiner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christine Gardiner","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000740562","display_name":"Jamin Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jamin Wang","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029826903","display_name":"Catherine A. Oleykowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catherine A. Oleykowski","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006686840","display_name":"Richard R. Gontarek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Gontarek","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111550602","display_name":"Glenn Van Aller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Glenn Van Aller","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043278576","display_name":"Seth A. Gilbert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Seth Gilbert","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002745302","display_name":"David S. Sutton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David S. Sutton","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067669966","display_name":"Peter J. Tummino","orcid":"https://orcid.org/0009-0009-1989-970X","observed_orcids":["https://orcid.org/0009-0009-1989-970X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter J. Tummino","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032556314","display_name":"Richard F. Wooster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard F. Wooster","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042569093","display_name":"Steven D. Knight","orcid":"https://orcid.org/0009-0000-0447-2062","observed_orcids":["https://orcid.org/0009-0000-0447-2062"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven D. Knight","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108495269","display_name":"Jeffrey R. Jackson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey R. Jackson","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035647861","display_name":"Dashyant Dhanak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dashyant Dhanak","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110131865","display_name":"Kurt R. Auger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kurt R. Auger","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"12_Supplement","first_page":"C63","last_page":"C63"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gsk2126458","display_name":"GSK2126458","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.8619999885559082},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.7870000004768372},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.6539999842643738},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.8610000014305115},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9670000076293945},{"id":"https://openalex.org/keywords/caspase-3-7-activation","display_name":"caspase-3/7 activation","score":0.8019999861717224},{"id":"https://openalex.org/keywords/breast-cancer-xenografts","display_name":"breast cancer xenografts","score":0.6549999713897705},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.8631618618965149},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.6573578119277954},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.6224521398544312},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.6171539425849915},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5872685313224792},{"id":"https://openalex.org/C107846503","wikidata":"https://www.wikidata.org/wiki/Q14876061","display_name":"mTORC2","level":5,"score":0.5841872692108154},{"id":"https://openalex.org/C2781322055","wikidata":"https://www.wikidata.org/wiki/Q423725","display_name":"Phosphoinositide 3-kinase","level":4,"score":0.5780162811279297},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.548384428024292},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5313851237297058},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5124362111091614},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.47997260093688965},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4378040134906769},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.42616069316864014},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4223487377166748},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4101461172103882},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3660900890827179},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28381532430648804},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23379483819007874},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0692848265171051}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-09-c63","doi":"https://doi.org/10.1158/1535-7163.targ-09-c63","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-09-c63","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2039568738","https://openalex.org/W2169303908","https://openalex.org/W2079647212","https://openalex.org/W2119855881","https://openalex.org/W2093637711","https://openalex.org/W1984777958","https://openalex.org/W1436721071","https://openalex.org/W2064538026","https://openalex.org/W2181371279"],"abstract_inverted_index":{"The":[0,15,331],"phosphoinositide":[1],"3-kinase":[2],"(PI3K)":[3],"pathway":[4],"is":[5],"among":[6],"the":[7,28,59,62,83,98,104,126,143,148,159,163,219,337],"most":[8],"commonly":[9],"activated":[10],"pathways":[11],"in":[12,20,33,90,111,136,147,167,189,197,240,252,262,290,300,307,316,326],"human":[13,34,91,244,349],"cancer.":[14,92],"biological":[16,332],"role":[17],"of":[18,24,30,43,52,61,79,87,101,115,129,162,194,202,210,221,228,237,243,260,271,286,299,305,319,334,340],"PI3K":[19,81,99,121],"growth":[21,191,233,303,314],"and":[22,27,39,82,106,134,139,180,213,235,276,293,323,343],"survival":[23],"cancer":[25,245,266,329],"cells":[26,199],"prevalence":[29],"activating":[31,85],"mutations":[32],"cancers":[35],"are":[36],"well":[37],"documented":[38],"a":[40,67,112,137,168,184,190,226,241,282,327],"significant":[41],"proportion":[42],"tumors":[44],"would":[45],"be":[46],"predicted":[47],"to":[48],"benefit":[49],"from":[50],"inhibition":[51,177,234,259],"this":[53,341],"pathway.":[54],"Here":[55],"we":[56],"report":[57],"on":[58],"characterization":[60],"pan-PI3K":[63],"pyridylsulfonamide":[64],"inhibitor":[65,78],"GSK2126458:":[66],"very":[68],"potent":[69,120,231],"(PI3K":[70],"app":[71],"Ki":[72],"=":[73],"19":[74],"pM),":[75],"reversible,":[76],"ATP-competitive":[77],"wild-type":[80],"\u2018hotspot\u2019":[84],"mutants":[86],"p110":[88],"found":[89],"GSK2126458":[93,124,157,224,247,306,335,344],"demonstrated":[94,248,310],"good":[95],"selectivity":[96],"for":[97,145,230,278],"family":[100],"enzymes":[102],"including":[103],"mTORC1":[105],"mTORC2":[107],"complexes,":[108],"when":[109],"evaluated":[110],"large":[113],"panel":[114],"protein":[116],"kinases.":[117],"Consistent":[118],"with":[119,183,200,208],"enzyme":[122],"inhibition,":[123],"decreased":[125],"cellular":[127],"levels":[128],"phosphorylated":[130],"AKT,":[131],"p70S6K,":[132],"PRAS40":[133],"ERK":[135],"concentration":[138,169,181],"time":[140,179],"dependent":[141,170,182,251,312],"manner,":[142],"IC50":[144,192],"pAKT":[146],"HCC1954":[149,198],"breast":[150,265,328],"carcinoma":[151],"cell":[152,203,222,232,238,267],"line":[153],"was":[154,178,218,274],"2":[155],"nM.":[156],"induced":[158],"nuclear":[160],"translocation":[161],"FOXO3a":[164],"transcription":[165],"factor":[166],"manner":[171],"that":[172],"mechanistically":[173],"appeared":[174],"bimodal.":[175],"Growth":[176],"3":[185,212],"day":[186],"exposure":[187],"resulting":[188],"(gIC50)":[193],"9":[195],"nM":[196],"evidence":[201],"death.":[204,223],"Cell":[205],"death":[206,239],"correlated":[207],"induction":[209,236],"caspase":[211],"7":[214],"activity":[215,229,255],"suggesting":[216],"apoptosis":[217],"mechanism":[220],"had":[225],"breadth":[227],"variety":[242],"cells.":[246],"robust,":[249],"dose":[250,311],"vivo":[253,301],"pharmacodynamic":[254],"as":[256],"measured":[257],"by":[258],"phospho-AKT":[261],"advanced":[263],"BT474":[264],"xenograft":[268,308],"tumors.":[269],"Inhibition":[270],"AKT":[272],"phosphorylation":[273],"rapid":[275],"lasted":[277],"several":[279,317],"hours":[280],"after":[281],"single":[283],"oral":[284],"administration":[285],"GSK2126458.":[287],"Transient":[288],"increases":[289],"plasma":[291],"insulin":[292],"blood":[294],"glucose":[295],"were":[296],"observed.":[297],"Evaluation":[298],"tumor":[302,313,321,324],"effects":[304],"models":[309,318],"delay":[315],"diverse":[320],"lineage":[322],"regression":[325],"xenograft.":[330],"profile":[333],"supports":[336],"clinical":[338,350],"advancement":[339],"compound":[342],"has":[345],"entered":[346],"Phase":[347],"I":[348],"trials.":[351],"Citation":[352],"Information:":[353],"Mol":[354],"Cancer":[355],"Ther":[356],"2009;8(12":[357],"Suppl):C63.":[358]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2014865890","counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
